Universitatsklinikum Erangen
Welcome,         Profile    Billing    Logout  
 0 Trials 
6 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Hamer, Hajo
NCT05219617 / 2022-001256-42: Investigate Efficacy and Safety of Carisbamate as Adjunctive Treatment for Seizures Associated With LGS in Children and Adults

Recruiting
3
252
Europe, US, RoW
Carisbamate
SK Life Science, Inc., SK Life Science, Inc
Seizures, Lennox Gastaut Syndrome
06/25
06/26
NCT05814523: To Evaluate the Efficacy, Safety, and Tolerability of Intravenous Ganaxolone Added to Standard of Care in Refractory Status Epilepticus (RSE)

Withdrawn
3
70
Europe, RoW
Ganaxolone, Placebo, Standard of care
Marinus Pharmaceuticals
Refractory Status Epilepticus
08/24
08/24
CENOR, NCT05747001: This is a Retrospective Study on the Use of CENOBAMATE as Adjunctive Treatment in Patients Suffering From Epilepsy in Early Access Program in Germany, France and UK

Completed
N/A
319
Europe
Aziende Chimiche Riunite Angelini Francesco S.p.A, Hippocrates Research
Focal Onset Seizure, Epilepsy
09/23
09/23
NCT06138808: 5-SENSE Score Validation Study

Enrolling by invitation
N/A
400
Europe, Canada, Japan, US, RoW
Stereoelectroencephalography (SEEG)
Duke University, Christian Doppler University Hospital
Epilepsy Intractable
11/25
11/25
Carreno, Orlando
NCT05219617 / 2022-001256-42: Investigate Efficacy and Safety of Carisbamate as Adjunctive Treatment for Seizures Associated With LGS in Children and Adults

Recruiting
3
252
Europe, US, RoW
Carisbamate
SK Life Science, Inc., SK Life Science, Inc
Seizures, Lennox Gastaut Syndrome
06/25
06/26
Quintas, Sofia
NCT05219617 / 2022-001256-42: Investigate Efficacy and Safety of Carisbamate as Adjunctive Treatment for Seizures Associated With LGS in Children and Adults

Recruiting
3
252
Europe, US, RoW
Carisbamate
SK Life Science, Inc., SK Life Science, Inc
Seizures, Lennox Gastaut Syndrome
06/25
06/26

Download Options